Brokers Issue Forecasts for Nutrien’s Q3 Earnings (NYSE:NTR)

Nutrien Ltd. (NYSE:NTRFree Report) – Research analysts at Zacks Research boosted their Q3 2026 earnings estimates for Nutrien in a research report issued to clients and investors on Monday, May 25th. Zacks Research analyst Team now anticipates that the company will earn $0.92 per share for the quarter, up from their previous estimate of $0.91. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Nutrien’s current full-year earnings is $5.45 per share.

Nutrien (NYSE:NTRGet Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.03. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. During the same period in the previous year, the firm posted $0.11 earnings per share. The business’s revenue was up 18.5% on a year-over-year basis.

Other equities research analysts also recently issued research reports about the stock. Wells Fargo & Company raised shares of Nutrien from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $77.00 to $100.00 in a report on Friday, March 13th. BNP Paribas Exane lowered shares of Nutrien from an “outperform” rating to a “neutral” rating in a research note on Monday, February 23rd. UBS Group decreased their price objective on shares of Nutrien from $67.00 to $65.00 and set a “sell” rating for the company in a report on Monday, May 11th. Barclays boosted their target price on Nutrien from $70.00 to $80.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 3rd. Finally, Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 target price for the company in a research report on Thursday, April 30th. Eleven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $82.75.

Check Out Our Latest Research Report on Nutrien

Nutrien Trading Down 0.2%

NYSE:NTR opened at $70.02 on Wednesday. Nutrien has a 1 year low of $53.03 and a 1 year high of $85.36. The stock has a market cap of $33.61 billion, a price-to-earnings ratio of 14.26, a PEG ratio of 0.64 and a beta of 0.64. The business has a fifty day moving average of $73.46 and a 200-day moving average of $68.30. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24.

Nutrien Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be issued a $0.55 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.1%. Nutrien’s dividend payout ratio is presently 44.81%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Guggenheim Capital LLC boosted its position in Nutrien by 2.2% during the 4th quarter. Guggenheim Capital LLC now owns 6,628 shares of the company’s stock worth $409,000 after acquiring an additional 145 shares during the period. Minot DeBlois Advisors LLC lifted its position in shares of Nutrien by 1.8% in the fourth quarter. Minot DeBlois Advisors LLC now owns 9,032 shares of the company’s stock worth $557,000 after purchasing an additional 164 shares in the last quarter. Banque Cantonale Vaudoise boosted its holdings in shares of Nutrien by 15.9% during the first quarter. Banque Cantonale Vaudoise now owns 1,198 shares of the company’s stock worth $90,000 after purchasing an additional 164 shares during the period. Gould Asset Management LLC CA boosted its holdings in shares of Nutrien by 4.4% during the first quarter. Gould Asset Management LLC CA now owns 3,933 shares of the company’s stock worth $297,000 after purchasing an additional 165 shares during the period. Finally, Smith Moore & CO. grew its position in Nutrien by 2.2% during the third quarter. Smith Moore & CO. now owns 7,642 shares of the company’s stock valued at $449,000 after purchasing an additional 168 shares in the last quarter. Hedge funds and other institutional investors own 63.10% of the company’s stock.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Stories

Earnings History and Estimates for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.